Compelling claims to capture the minds of consumers
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSIQVIA Consumer Health, in partnership with ObvioHealth, has launched a fully decentralized clinical trial with Jovie USA to bring the first FDA-approved goat milk-based infant formula to the United States. The innovative study design is the first of its kind for infant formula, allowing parents and their newborns to participate in the trial from their homes without the need for in-clinic visits.
Designed in collaboration with the FDA to increase the probability of regulatory success upon the completion of the trial, the study will evaluate whether babies fed Jovie’s goat milk-based formula show similar growth to babies who are fed cow milk-based formula or breast milk, the CDC’s growth standard.
To enable at-home participation, those taking part receive a scale and measuring devices and are trained during video calls by pediatric nurses on how to take the vital measurements essential to tracking healthy newborn growth. Nurses provide close oversight during measurements to ensure all is done correctly. The caregivers then use ObvioHealth’s app to report weekly measurements throughout the duration of the study.
The COACH (Clinical Oversight and Coordination Hub) team provides end-to-end, personalized assistance to caregivers via in-app messaging, phone, or video calls and remotely monitors trial data to ensure patient safety. The DCT platform is programmed to alert the COACH team of potential adverse events, such as an infant’s growth falling below the CDC threshold.
“Decentralized trials have been in high demand, yet their application in studies involving newborns has been notably limited thus far,” pointed out Dr Volker Spitzer, Vice-President, Global R&D/RWE Services, IQVIA Consumer Health. “Our collaboration with Jovie and ObvioHealth demonstrates the potential of such an innovative approach in accessing challenging-to-engage infant populations and their caregivers. We are thrilled to contribute to this initiative, which simplifies substantially parental involvement and eliminating the need for inconvenient clinic visits.”
In the U.S., four companies control approximately 90 percent of the infant formula market, an issue highlighted in 2022 at the peak of the U.S.’s formula shortage. Few other options are available to U.S. parents. Globally, goat milk infant formula is widely accepted, appreciated for its easier digestibility and nutrient absorption, and proven in clinical trials to be as safe and effective as cow milk formula and breastmilk.
“Parents in the U.S. who can’t or don’t want to breastfeed deserve more options,” said Jan van Marwijk Kooij, CEO of Jovie USA. “We are excited to have the opportunity to bring the first goat milk-based infant formula to the U.S. market, and we believe this trial will prove to regulators and parents alike that goat milk-based infant formula is an excellent choice.”
Compelling claims to capture the minds of consumers
Shape the future of consumer health.
See how we partner with organizations across the healthcare ecosystem, from emerging biotechnology and large pharmaceutical, to medical technology, consumer health, and more, to drive human health forward.